Enrico N De Toni

Enrico N De Toni

Ludwig Maximilians Universität München - Munich / Germany
Medical and Health Sciences / Internal Medicine
AD Scientific Index ID: 1761959
Ludwig Maximilian University of Munich
person_outline Enrico N De Toni's MOST POPULAR ARTICLES
1-) Tremelimumab plus durvalumab in unresectable hepatocellular carcinomaGK Abou-Alfa, G Lau, M Kudo, SL Chan, RK Kelley, J Furuse, ...NEJM evidence 1 (8), EVIDoa2100070, 20225632022
2-) The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspectsW Tang, Z Chen, W Zhang, Y Cheng, B Zhang, F Wu, Q Wang, S Wang, ...Signal transduction and targeted therapy 5 (1), 87, 20205452020
3-) Phase 3 randomized, open-label, multicenter study of tremelimumab (T) and durvalumab (D) as first-line therapy in patients (pts) with unresectable hepatocellular carcinoma …GK Abou-Alfa, SL Chan, M Kudo, G Lau, RK Kelley, J Furuse, ...Journal of Clinical Oncology 40 (4_suppl), 379-379, 20223202022
4-) Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinomaJ Ricke, HJ Klümpen, H Amthauer, I Bargellini, P Bartenstein, EN de Toni, ...Journal of hepatology 71 (6), 1164-1174, 20193282019
5-) The role of the novel Th17 cytokine IL-26 in intestinal inflammationJ Dambacher, F Beigel, K Zitzmann, EN De Toni, B Göke, HM Diepolder, ...Gut 58 (9), 1207-1217, 20093172009